Genetic Technologies (GENE) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Genetic Technologies Limited has reported significant growth with a 500% increase in commercial samples for its geneType portfolio and a successful expansion into global markets, including the U.S. and Australia. The company has launched a comprehensive direct-to-consumer digital campaign to drive sales of its geneType Risk Assessments Tests and is developing an advanced risk assessment test that includes over 200 genes. Furthermore, GTG has strengthened its financial position through a US$2 million offering and shareholders’ approval to raise up to $15 million.
For further insights into GENE stock, check out TipRanks’ Stock Analysis page.